Headquarters
418, RUE DU MAS DE VERCHANT, MONTPELLIER 34000, FR
MONTPELLIER, FR
DOLINNOV
From the company
Dolinnov is a biotech company developing Precision Pump Modulators (PPMs), a novel class of non-opioid medicines for chronic pain. It is the first company worldwide to develop a lipid antisense oligonucleotide (L-ASO) therapy targeting FXYD2, a regulator of neuronal excitability in the DRG, to treat neuropathic and inflammatory chronic pain, including pain associated with rare diseases.
Products & services offered
Facilities
Send your requirements
Quantities, certifications, and timing.